The Merger of Alcon and Novartis has been Completed 

Alcon and Novartis have announced the completion of their merger. This is a very significant event in the ophthalmic world.  Alcon was already a leader is providing pharmaceuticals, lasers, and intraocular lenses. As Kevin Buehler, head of Alcon stated, “Through this merger, Alcon now truly serves the full lifecycle of patient needs across acute and chronic eye diseases, ophthalmic conditions treated with surgical procedures, and multiple options to address the correction of refractive error.” 

We have had a longstanding relationship with Alcon. Our excimer lasers are all manufactured and maintained by Alcon and much of the surgical equipment that we use at the surgery centers are manufactured by Alcon. In addition, we use Alcon intraocular lenses. Because of this, we are really excited about the merger and know that Novartis will be able to support expanded research and development which will inevitably result in new products that will help our patients.

 This is an exciting event for ophthalmology and our patients and we look forward to our future

Bernie’s Burble-

Many of us at The Eye Clinic of Texas attended an event supporting Texas Equusearch and Tim Miller last night. There were close to 600 people who had a very enjoyable evening hearing about the remarkable work that Mr. Miller and his organization, Texas Equusearch, are doing. Mr. Miller explained how and why he started Texas Equusearch.

Several weeks ago, I had the pleasure of interviewing Mr. Miller and he went into great detail about the loss of his daughter, Laura, and how it affected his life. When Laura was finally found, Mr. Miller made a commitment to her to help others who are in a similar situation. What is evident is that Mr. Miller is genuine in his feelings and his commitment to help others. He is a real hero and his story is incredible.

This interview is available for viewing on our website – I would recommend it to anyone who is interested in Mr. Miller and his wonderful organization 


During my long career in ophthalmology, I’ve been proud to play a leading role in many regional, state-wide, and national organizations dedicated to cutting-edge eye care.

Recently, I attended the American Society of Cataract and Refractive Surgeons’ meeting in San Diego.  ASCRS (pronounced ascris), is a group of some 5,000 ophthalmologists who meet annually to review what is happening in the world of eye surgery.  I served on their founding board and continue to play a role in the organization.

At the April meeting, I had the opportunity to formally review 50 of the best papers presented and then to discuss their importance at a seminar called the Clinical Carryout Session.  I shared this unique opportunity – and honor – with seven other ophthalmologists from around the country.

The essence of the general meeting and the Carryout Session is this:  impressive and imaginative improvements and innovations are being made continually in eyecare.  An amazing amount of money and energy is being spent to research and develop new and improved treatments for people with cataracts as well as for people who do not want to wear glasses or contacts.

The future is bright and clear. This is an exciting time to be an ophthalmologist and to be able to help people see better and continue to see well.

Bernie Milstein

The Voice of Van- I recently attended the  American Society of Cataract and Refractive Surgeon (ASCRS) meetings in San Diego and I am very excited to learn of this new technology available for our glaucoma patients.  I attended a full day of glaucoma lectures.  One new thing about glaucoma treatment is the use of Ex-PRESS shunt in glaucoma surgery. It is a relatively new device that aids ophthalmologist to control eye pressures better for patients who have maximized their eye drop treatment.  It’s inserted in the eye as a surgical procedure.  The fluid inside the eye is shunted through this mini tube and drains to the conjunctival layer of the eye.  The Ex-PRESS gives a more precise control of the fluid level and thus, controls the eye pressure better.  The goal of this device is to reduce or eliminate the use of eye drops and better control the eye pressures.

Dr. Da-Thuy Van, D.O.


We are happy to have Dr. Stefan Trocme on our team.  Dr. Trocme is a Board Certified ophthalmologist here from Sweeden to head up a research study to help people with dry eye disease.

Dr. Trocme specializes in:

  • treatment of the cornea – dry eye, ocular allergies, ocular inflammation, and eye infections;
  • anterior segment surgery – cataract and pterygium; and
  • refractive surgery – LASIK and PRK.

Dr. Trocme is the former Director of Ocular Surface Services at Case Western

Reserve University Hospital in Cleveland, Ohio, the former Director of Cornea Services at UTMB in Galveston, and he has participated in numerous clinical trials for the treatment of ocular infection, dry eye, and cataracts.

Welcome to First Look, the newest way the doctors at The Eye Clinic of Texas are helping Texans keep their vision strong and healthy.

We’re looking forward to sharing with you the newest advances in eye health and tips on caring for your eyes. Please let us know if there are specific issues you’d like for us to address – we want to answer your questions! And check back often for reports on topics from the latest in LASIK Vision Correction, to when to try “monovision,” to how to keep your eyes from getting sunburned this summer.

Hopefully we’ll be able to provide you with a first look into staying healthy and making the most of your own vision.